Clinical Trials

Our office is actively engaged in clinical research. In the past, we have participated in trials of new medications for BPH, prostatitis, and urge incontinence. Currently we are enrolling patients in the following active trials:

  1. Dendreon 9902B Study- Provenge immunotherapy trial for hormone resistant prostate cancer with documented metastases but no symptoms of pain.

  2. Dendreon P-11 Study - Provenge immunotherapy trial for rising PSA after prostate cancer surgery with no evidence of metastasis.

We also belong to Main Line Health Comprehensive Cancer Program which has several trials available for the treatment of kidney, bladder, and prostate cancer.

Specializing in Minimally Invasive Treatment for Enlarged Prostate

• Single nonsurgical office-basedtreatment

• Safe and highly effective

• Resume normal activity within 24 hours

• Medicare and insurance approved

Learn more about Greenlight Laser

Watch a video about robotic surgery

daVinci® Robotic Prostatectomy

Drs. Bernstein and Lanchoney specialize in state-of-the-art, no-needle, no-scalpel vasectomy

Learn more at Vasectomy.com